ID: ALA2147354

Max Phase: Preclinical

Molecular Formula: C6H8ClNO2S

Molecular Weight: 157.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCc1cscc1C(=O)O

Standard InChI:  InChI=1S/C6H7NO2S.ClH/c7-1-4-2-10-3-5(4)6(8)9;/h2-3H,1,7H2,(H,8,9);1H

Standard InChI Key:  LHOWLRIUOSANES-UHFFFAOYSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 157.19Molecular Weight (Monoisotopic): 157.0197AlogP: 0.91#Rotatable Bonds: 2
Polar Surface Area: 63.32Molecular Species: ZWITTERIONHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.31CX Basic pKa: 8.84CX LogP: -1.73CX LogD: -1.74
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.67Np Likeness Score: -0.34

References

1. Hawker DD, Silverman RB..  (2012)  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.,  20  (19): [PMID:22944334] [10.1016/j.bmc.2012.08.009]

Source